Teva Gets Pfizer Blood Thinner Patents Invalidated In UK
A London judge has axed four of Pfizer and Bristol-Myers Squibb's European drug patents on blood thinner Eliquis that were challenged by Teva Pharmaceuticals in its suit over a planned alternative,...To view the full article, register now.
Already a subscriber? Click here to view full article